Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ALBIREO PHARMA, INC. (ALBO)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Sep-30-16 | Dec-31-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 14.0 | | | | | | | |
| Asset turnover | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.4 | 0.0 | |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -496.3% | -2409.6% | -3676.6% | | | | 9581.0% | |
| ROIC (including intangibles) | -95.7% | -445.4% | -292.5% | -223.6% | -168.4% | -96.2% | -3079.7% | 129.2% |
| ROE | -11.4% | -53.1% | -65.6% | -30.9% | -38.0% | -30.2% | 52.6% | 57.5% |
| ROA | -6.7% | -33.7% | -37.0% | -20.4% | -33.9% | -22.5% | 48.2% | -67.8% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 29.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | 91.1 |
| Days payables outstanding | 1,753.9 | | | | | -14.3 | | 437.3 |
| Days inventory outstanding | 52.2 | | | | | | | |
| Cash conversion cycle | -1,672.3 | | | | | 14.3 | | -346.3 |
|